Morten Würtz

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Atrial Fibrillation

Percutaneous Coronary Intervention

Antiplatelet Therapy

Direct Oral Anticoagulants

Top Venues

European heart journal. Cardiovascular pharmacotherapy

European heart journal

European journal of clinical investigation

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Morten Würtz, Kevin Kris Warnakula Olesen, Deepak L Bhatt, Salim Yusuf, Eva Muehlhofer, John W Eikelboom, Michael Maeng
Net clinical benefit of extended dual pathway inhibition according to Baseline risk in patients with chronic coronary syndrome: a COMPASS substudy. European heart journal. Cardiovascular pharmacotherapy (2024)
Morten Würtz, Kevin Kris Warnakula Olesen, Deepak L Bhatt, Salim Yusuf, Eva Muehlhofer, John W Eikelboom, Michael Maeng
Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Morten Würtz, Kevin Kris Warnakula Olesen, Deepak L Bhatt, Salim Yusuf, Eva Muehlhofer, John W Eikelboom, Michael Maeng
Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Thomas Jensen, Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Morten Würtz, Martin Bødtker Mortensen, Christine Gyldenkerne, Troels Thim, Bjarne Linde Nørgaard, Jesper Møller Jensen, Steen Dalby Kristensen, Jens Cosedis Nielsen, John William Eikelboom, Michael Mæng
Antithrombotic treatment beyond one year after percutaneous coronary intervention in patients with atrial fibrillation. European heart journal. Cardiovascular pharmacotherapy (2022)
Thomas Jensen, Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Morten Würtz, Jens Cosedis Nielsen, Lisette Okkels Jensen, Morten Madsen, Troels Thim, Steen Dalby Kristensen, Gregory Yoke Hong Lip, Michael Mæng
CHA2 DS2 -VASc impact on risk following percutaneous coronary intervention in atrial fibrillation. European journal of clinical investigation (2021)
Morten Würtz, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen, John William Eikelboom, Moman Aladdin Mohammad, David Erlinge, Steen Dalby Kristensen, Michael Maeng
Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score. European heart journal (2021)
Morten Würtz, Erik Lerkevang Grove, Priscila Corraini, Kasper Adelborg, Jens Sundbøll, Szimonetta Komjáthiné Szépligeti, Erzsébet Horváth-Puhó, Henrik Toft Sørensen
Comorbidity and risk of venous thromboembolism after hospitalization for first-time myocardial infarction: A population-based cohort study. Journal of thrombosis and haemostasis : JTH 18 (8) (2020)